Inhibitory effect of 8-oxo-7,8-dihydro-2′-deoxyguanosine on the growth of KG-1 myelosarcoma in Balb/c nude mice

Leukemia Research

Volumn 30, Issue 11, 2006, Pages 1425-1436

  Choi, Seongwon ^a   Choi, Hyun Ho ^a   Choi, Jun Ho ^b   Yoon, Byung Hak ^a   You, Ho Jin ^c   Hyun, Jin Won ^d   Kim, Ja Eun ^a   Ye, Sang Kyu ^a   Chung, Myung Hee ^a  

^a Seoul National University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Chosun University   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

Author keywords

8 Oxo 7,8 dihydro 2 deoxyguanosine; 8 Oxo 7,8 dihydroguanine; 8 Oxo 7,8 dihydroguanine glycosylase; Apoptosis; KG 1; Nude mice

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE; CYCLINE; DEOXYGUANOSINE; DNA FRAGMENT; PROTEIN P16; PROTEIN P27; TIOGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL STRAIN U937; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; IN VIVO STUDY; LEUKEMIA CELL LINE; MALE; MOUSE; MYELOSARCOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; STRUCTURE-ACTIVITY RELATIONSHIP; THIOGUANINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; U937 CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33748095351     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.020     Document Type: Article

References (70)

1. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387 (1997) 147
2. Wu L.L., Chiou C.C., Chang P.Y., and Wu J.T. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339 (2004) 1
3. Shibutani S., Takeshita M., and Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349 (1991) 431
4. Kamiya H., Miura K., Ishikawa H., Inoue H., Nishimura S., and Ohtsuka E. c-Ha-ras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res 52 (1992) 3483
5. Yarborough A., Zhang Y.J., Hsu T.M., and Santella R.M. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res 56 (1996) 683
6. Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., et al. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 57 (1997) 1281
7. Suzuki J., Inoue Y., and Suzuki S. Changes in the urinary excretion level of 8-hydroxyguanine by exposure to reactive oxygen-generating substances. Free Radic Biol Med 18 (1995) 431
8. Wilson V.L., Taffe B.G., Shields P.G., Povey A.C., and Harris C.C. Detection and quantification of 8-hydroxydeoxyguanosine adducts in peripheral blood of people exposed to ionizing radiation. Environ Health Perspect 99 (1993) 261
9. Hyun J.W., Cheon G.J., Kim H.S., Lee Y.S., Choi E.Y., Yoon B.H., et al. Radiation sensitivity depends on OGG1 activity status in human leukemia cell lines. Free Radic Biol Med 32 (2002) 212
10. Baik S.C., Youn H.S., Chung M.H., Lee W.K., Cho M.J., Ko G.H., et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 56 (1996) 1279
11. Chung M.H., Kasai H., Nishimura S., and Yu B.P. Protection of DNA damage by dietary restriction. Free Radic Biol Med 12 (1992) 523
12. Fraga C.G., Motchnik P.A., Shigenaga M.K., Helbock H.J., Jacob R.A., and Ames B.N. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci USA 88 (1991) 11003
13. Verhagen H., Poulsen H.E., Loft S., van Poppel G., Willems M.I., and van Bladeren P.J. Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis 16 (1995) 969
14. Lee Y.S., Lee H.S., Park M.K., Hwang E.S., Park E.M., Kasai H., et al. Identification of 8-hydroxyguanine glycosylase activity in mammalian tissues using 8-hydroxyguanine specific monoclonal antibody. Biochem Biophys Res Commun 196 (1993) 1545
15. Tchou J., Kasai H., Shibutani S., Chung M.H., Laval J., Grollman A.P., et al. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA 88 (1991) 4690
16. Shinmura K., Yamaguchi S., Saitoh T., Takeuchi-Sasaki M., Kim S.R., Nohmi T., et al. Adenine excisional repair function of MYH protein on the adenine:8-hydroxyguanine base pair in double-stranded DNA. Nucl Acids Res 28 (2000) 4912
17. Oda H., Nakabeppu Y., Furuichi M., and Sekiguchi M. Regulation of expression of the human MTH1 gene encoding 8-oxo-dGTPase. Alternative splicing of transcription products. J Biol Chem 272 (1997) 17843
18. Daroui P., Desai S.D., Li T.K., Liu A.A., and Liu L.F. Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death. J Biol Chem 279 (2004) 14587
19. Aruoma O.I., Halliwell B., and Dizdaroglu M. Iron ion-dependent modification of bases in DNA by the superoxide radical-generating system hypoxanthine/xanthine oxidase. J Biol Chem 264 (1989) 13024
20. Pourquier P., Ueng L.M., Fertala J., Wang D., Park H.J., Essigmann J.M., et al. Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7,8-Dihydro-8-oxoguanine and 5-hydroxycytosine. J Biol Chem 274 (1999) 8516
21. McCormack J.J., and Johns D.G. Purine antimetabolites. In: Chabner B.A. (Ed). Pharmacologic principles of cancer treatment (1998), WB Sanders Co., Philadelphia 213
22. Dervieux T., Blanco J.G., Krynetski E.Y., Vanin E.F., Roussel M.F., and Relling M.V. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res 61 (2001) 5810
23. Gunnarsdottir S., Rucki M., and Elfarra A.A. Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice. J Pharmacol Exp Ther 301 (2002) 77
24. Allan P.W., and Bennett Jr. L.L. 6-Methylthioguanylic acid, a metabolite of 6-thioguanine. Biochem Pharmacol 20 (1971) 847
25. Davidson J.D. Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L1210 leukemia in vitro. Cancer Res 20 (1960) 225
26. Christie N.T., Drake S., Meyn R.E., and Nelson J.A. 6-Thioguanine-induced DNA damage as a determinant of cytotoxicity in cultured Chinese hamster ovary cells. Cancer Res 44 (1984) 3665
27. Krynetskaia N.F., Krynetski E.Y., and Evans W.E. Human RNase H-mediated RNA cleavage from DNA-RNA duplexes is inhibited by 6-deoxythioguanosine incorporation into DNA. Mol Pharmacol 56 (1999) 841
28. Crabtree G.W., Nelson J.A., and Parks Jr. R.E. Failure of 6-thioGMP to inhibit guanylate kinase in intact cells. Biochem Pharmacol 26 (1977) 1577
29. Nelson D.J., Bugge C., and Krasny H.C. Oxypurine and 6-thiopurine nucleoside triphosphate formation in human erythrocytes. Adv Exp Med Biol 76A (1977) 121
30. Hyun J.W., Choi J.Y., Zeng H.H., Lee Y.S., Kim H.S., Yoon S.H., et al. Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1. Oncogene 19 (2000) 4476
31. Hyun J.W., Jung Y.C., Kim H.S., Choi E.Y., Kim J.E., Yoon B.H., et al. 8-Hydroxydeoxyguanosine causes death of human leukemia cells deficient in 8-oxoguanine glycosylase 1 activity by inducing apoptosis. Mol Cancer Res 1 (2003) 290
32. Machado E.A., Gerard D.A., Lozzio C.B., Lozzio B.B., Mitchell J.R., and Golde D.W. Proliferation and differentiation of human myeloid leukemic cells in immunodeficient mice: electron microscopy and cytochemistry. Blood 63 (1984) 1015
33. Tomayko M.M., and Reynolds C.P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24 (1989) 148
34. Maulik N., Kagan V.E., Tyurin V.A., and Das D.K. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol 274 (1998) H242
35. Choi S., Kim K.W., Choi J.S., Han S.T., Park Y.I., Lee S.K., et al. Angiogenic activity of beta-sitosterol in the ischaemia/reperfusion-damaged brain of Mongolian gerbil. Planta Med 68 (2002) 330
36. Choi J., Yoon S.H., Kim J.E., Rhee K.H., Youn H.S., and Chung M.H. Gene-specific oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Int J Cancer 99 (2002) 485
37. Choi J., Kim D.Y., Hyun J.W., Yoon S.H., Choi E.M., Hahm K.B., et al. Measurement of oxidative damage at individual gene levels by quantitative PCR using 8-hydroxyguanine glycosylase (OGG1). Mutat Res 523 (2003) 225
38. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54 (1994) 4855
39. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49
40. Banti S., Miller P.J., Parker C.D., Ananth S.L., Horn L.L., Babu Y.S., et al. Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX. Int Immunopharmacol 2 (2002) 913
41. Germeraad W.T., Kawamoto H., Itoi M., Jiang Y., Amagai T., Katsura Y., et al. Development of thymic microenvironments in vitro is oxygen-dependent and requires permanent presence of T-cell progenitors. J Histochem Cytochem 51 (2003) 1225
42. Nakazawa Y., Kamijo T., Koike K., and Noda T. ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins. J Biol Chem 278 (2003) 27888
43. Craig C., Wersto R., Kim M., Ohri E., Li Z., Katayose D., et al. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14 (1997) 2283
44. Krude T., Jackman M., Pines J., and Laskey R.A. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88 (1997) 109
45. Paternot S., Coulonval K., Dumont J.E., and Roger P.P. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J Biol Chem 278 (2003) 26533
46. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481
47. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
48. Wesselborg S., Engels I.H., Rossmann E., Los M., and Schulze-Osthoff K. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93 (1999) 3053
49. Wolf B.B., Schuler M., Echeverri F., and Green D.R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 274 (1999) 30651
50. Kasai H., Crain P.F., Kuchino Y., Nishimura S., Ootsuyama A., and Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 7 (1986) 1849
51. Han B.G., Kim H.S., Rhee K.H., Han H.S., and Chung M.H. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils. Pharmacol. Res. 32 (1995) 201
52. Briscoe W.T., and Cotter L.E. The effects of neighboring bases on N-methyl-N-nitrosourea alkylation of DNA. Chem Biol Interact 52 (1984) 103
53. Briscoe W.T., and Cotter L.E. DNA sequence has an effect on the extent and kinds of alkylation of DNA by a potent carcinogen. Chem Biol Interact 56 (1985) 321
54. Bohr V.A., Phillips D.H., and Hanawalt P.C. Heterogeneous DNA damage and repair in the mammalian genome. Cancer Res 47 (1987) 6426
55. Quan T.H., and State J.C. Preferential DNA damage in the p53 gene by benzo[a]pyrene metabolites in cytochrome P4501A1-expressing xeroderma pigmentosum group A cells. Mol Carcinog 16 (1996) 32
56. Hayakawa H., Hofer A., Thelander L., Kitajima S., Cai Y., Oshiro S., et al. Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry 38 (1999) 3610
57. -, human immunodeficiency virus-1 reverse transcriptase, and rat polymerase β. Biochemistry 36 (1997) 6069
58. Licastro F., Sarafian T., Verity A.M., and Walford R.L. Inhibition of polymerases-alpha and -beta completely blocks DNA repair induced by UV irradiation in cultured mouse neuronal cells. Biochem Biophys Res Commun 132 (1985) 929
59. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41 (1997) 646
60. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001) 759
61. Sanchez-Ramos J., Overvik E., and Ames B.A. A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 3 (1994) 197
62. Iida T., Furuta A., Nishioka K., Nakabeppu Y., and Iwaki T. Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain. Acta Neuropathol (Berl) 103 (2002) 20
63. Lovell M.A., Xie C., and Markesbery W.R. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res 855 (2000) 116
64. Audebert M., Charbonnier J.B., Boiteux S., and Radicella J.P. Mitochondrial targeting of human 8-oxoguanine DNA glycosylase hOGG1 is impaired by a somatic mutation found in kidney cancer. DNA Repair (Amst) 1 (2002) 497
65. Farrington S.M., Tenesa A., Barnetson R., Wiltshire A., Prendergast J., Porteous M., et al. Germline susceptibility to colorectral cancer due to base-excision repair gene defects. Am J Hum Genet 77 (2005) 112
66. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1513
67. Hagiwara A., Kitajima Y., Sato S., and Miyazaki K. Allelic loss of the DNA repair gene OGG1 against oxidative damage in esophageal squamous cell carcinoma. Oncol Rep 13 (2005) 1009
68. Sakumi K., Tominaga Y., Furuichi M., Xu P., Tsuzuki T., Sekiguchi M., et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res 63 (2003) 902
69. Trzeciak A.R., Nyaga S.G., Jaruga P., Lohani A., Dizdaroglu M., and Evans M.K. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 25 (2004) 1359
70. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550